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Abstract
Background: Nanoparticle (NP) toxicity testing comes with many challenges. Characterization of the test substance
is of crucial importance and in the case of NPs, agglomeration/aggregation state in physiological media needs to
be considered. In this study, we have addressed the effect of agglomerated versus single particle suspensions of
nano- and submicron sized gold on the inflammatory response in the lung. Rats were exposed to a single dose of
1.6 mg/kg body weight (bw) of spherical gold particles with geometric diameters of 50 nm or 250 nm diluted
either by ultrapure water or by adding phosphate buffered saline (PBS). A single dose of 1.6 mg/kg bw DQ12
quartz was used as a positive control for pulmonary inflammation. Extensive characterization of the particle
suspensions has been performed by determining the zetapotential, pH, gold concentration and particle size
distribution. Primary particle size and particle purity has been verified using transmission electron microscopy (TEM)
techniques. Pulmonary inflammation (total cell number, differential cell count and pro-inflammatory cytokines), cell
damage (total protein and albumin) and cytotoxicity (alkaline phosphatase and lactate dehydrogenase) were
determined in bronchoalveolar lavage fluid (BALF) and acute systemic effects in blood (total cell number,
differential cell counts, fibrinogen and C-reactive protein) 3 and 24 hours post exposure. Uptake of gold particles in
alveolar macrophages has been determined by TEM.
Results: Particles diluted in ultrapure water are well dispersed, while agglomerates are formed when diluting in
PBS. The particle size of the 50 nm particles was confirmed, while the 250 nm particles appear to be 200 nm using
tracking analysis and 210 nm using TEM. No major differences in pulmonary and systemic toxicity markers were
observed after instillation of agglomerated versus single gold particles of different sizes. Both agglomerated as well
as single nanoparticles were taken up by macrophages.
Conclusion: Primary particle size, gold concentration and particle purity are important features to check, since
these characteristics may deviate from the manufacturer’s description. Suspensions of well dispersed 50 nm and
250 nm particles as well as their agglomerates produced very mild pulmonary inflammation at the same mass
based dose. We conclude that single 50 nm gold particles do not pose a greater acute hazard than their
agglomerates or slightly larger gold particles when using pulmonary inflammation as a marker for toxicity.
Background
The small size and subsequent relative increase in sur-
face area-to-volume ratios of nanoparticles (NPs) results
in special and desired properties for which NPs are
engineered. It is hypothesized that this also contributes
to making nanoparticles chemically more reactive lead-
ing to unexpected and aberrant effects upon interaction
with biological systems compared to sub-micron sized
particles of the same material. In a number of studies,
the toxicity of nanoparticles (NPs) has been related to
their small size and therefore high surface area per unit
mass as well as proportionally having more atoms on
the surface available for chemical reactions [1-7].
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the test substance is of crucial importance in order to
understand the parameters that can be used to predict
the hazard of NPs. Primary particle size, shape, surface
area, surface chemistry, surface charge, solubility or dis-
solution rate, purity and agglomeration state can all
influence NPs toxicity [8]. In this study, the focus is on
agglomeration state of particles of two different sizes
and how this can influence the biological response after
administration into the lung. Agglomeration of particles
is a basic process that results in a reduction of surface
free energy by increasing their size and decreasing their
surface area. Agglomeration of nanoparticles is due to
adhesion of particles to each other by weak forces lead-
ing to (sub)micronsized entities. In contrast, nanoparti-
cle aggregates are due to the formation of covalent or
metallic bonds that cannot be easily disrupted. Both
agglomeration and aggregation raise questions how to
address the evaluation of safety of NPs when they are
no longer in the nano range, but are present as larger
entities [9]. It is not known whether agglomerated parti-
cles could become single particles again when intro-
duced in a biological system, while several studies have
s h o w nt h a ts i n g l ep a r t i c l e sh a v et h ea b i l i t yt of o r m
agglomerates in a biological matrix [10,11]. From a toxi-
cological perspective, it is important to determine how
the human body deals with single nanoparticles com-
pared to agglomerates. In the workplace, inhalation of
engineered nanoparticles is a realistic exposure scenario
during production and handling [12]. Nanoparticles can
exist in the form of single (primary) particles as well as
agglomerates or aggregates.
A l s ot h ep r i m a r ys i z eo fap a r t i c l e( n a n o -v e r s u ss u b -
micron sized) could result in a different biological
r e s p o n s e .I ti sc u r r e n t l yt h o u g h tt h a ts i n g l en a n o p a r t i -
cles could (also) pose a greater hazard compared to lar-
ger particles due to their ability to translocate across
barriers [13,14] and possibly to by-pass the pulmonary
immune system e.g. by less efficient macrophage uptake
[15]. The impact of agglomeration state of particles on
these effects is not extensively studied.
Colloidal gold particles of 50 nm and 250 nm with a
citrate coating are chosen as model particles to study
effects on pulmonary endpoints, since they can be
synthesized with a narrow size distribution as stable sus-
pensions. Toxic effects of gold nanoparticles have been
observed in vitro. For example, 14-nm colloidal gold
particles were found to cross the cell membrane of der-
mal fibroblasts in culture and accumulate into vacuoles.
The presence of the particles is responsible for abnor-
mal actin filaments and extracellular matrix constructs,
thereby inducing adverse effects on cell viability [16].
Conflicting results have been obtained regarding
the cytotoxicity of gold, ranging from non-cytotoxic for
15 nm particles and 3.5 +/- 0.7 nm particles capped
with lysine and poly-L-lysine [17] and to cytotoxic for
1.2 and 1.4 nm particles [18]. Gold 2 nm nanoparticles
functionalized with cationic groups were moderately
toxic in contrast to particles with anionic groups that
were not toxic [19]. Gold particles have also been used
to determine the fate as a function of size after different
exposure routes. To what extent the agglomeration state
will influence this, is largely unknown. In most studies,
particles have been administered in an agglomerated
state or as a mix of single and agglomerated particles
via intravenous injection, intratracheal instillation and
inhalation. After inhalation of nanogold particles (with a
primary size of 5-8 nm and present in the aerosol as
agglomerates of 30-110 nm or at least smaller than 100
nm, respectively), small quantities of particles translo-
cate from the lung to other organs [20,21]. After intra-
venous injection [22] and intratracheal instillation
[23,24], nano-sized particles have the ability to reach
more distal regions of the body compared to their larger
counterparts.
In this study we determine to what extend the
agglomeration state of 50 nm and 250 nm particles
influences pulmonary effects in the rat. A single dose of
1.6 mg/kg body weight of spherical gold particles of
either 50 nm or 250 nm is intratracheally instilled in the
rat lung after diluting either by 1/10 volume of ultrapure
water to obtain single particles or by 1/10 volume of
10× phosphate buffered saline (PBS) to obtain agglomer-
ates. This method of delivery was chosen over the phy-
siological route of exposure via inhalation based on the
possibility to administer particle solutions containing
single particles versus agglomerates, more exact dosing,
reduction of costs as well as less complexity in exposure
of the animals. Intratracheal instillation is a widely
accepted alternative for delivery of particles to the lung
[25,26].
Results
Characterization of particles
The 50 nm and 250 nm gold particles were custom pre-
pared at a concentration of 2 mg/ml and have a citrate
shell for stabilization. Diluting the 50 nm particle solu-
tion using ultrapure water did not result in a colour
change and particle size distribution measurements
using the Nanosight apparatus indicated a highest peak
size (size distribution peak with most particles) and
mean particle size of around 50 nm (table 1), indicating
that the citrate shell remains stabilized. Diluting the
50 nm particles using 1 part 10× PBS and 9 parts
50 nm particle suspension to obtain a physiological
solution resulted in a colour change from red to blue
with the highest peak and mean particle size above
100 nm indicating the formation of agglomerates [22].
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sion for approximately 5 minutes. Then particles started
to precipitate at the bottom of the tube with a clearer
aqueous solution on top. The resulting cluster of gold
particles could no longer be homogenized by sonication.
This effect was not observed for any other particle dilu-
tion that has been prepared. Therefore, 50 nm particles
were mixed with PBS immediately before instillation
and particle size distribution was measured directly
afterwards to avoid this phenomenon. The highest peak
size and mean particle size of 250 nm particles in ultra-
pure water were similar as indicated by a single distribu-
tion peak determined in the Nanosight apparatus.
Dilution by using 10× PBS resulted in larger agglomer-
ates with a large size distribution (table 1).
All solutions were electrically stabilized based on zeta-
potentials (between -40 and -60 mV) for single particles
solutions as well as agglomerates (table 1). The pH mea-
surement of the 50 nm and 250 nm gold particle solu-
tions as well as the control solution indicated that they
are in the physiological range of pH 6.4-7.0.
According to the supplier, the concentration of the
gold particles suspensions should be 2 mg/ml. ICP-MS
measurements revealed a lower concentration of 0.9 ±
0.02 mg/ml for 50 nm particles and 1.1 ± 0.02 mg/ml
for 250 nm particles. The administered dose was
405 μg/rat equivalent to 1.6 mg/kg body weight (bw).
Using the Nanosight apparatus (table 1) as well as
TEM (figure 1A and 1B), the particle size of the 50 nm
particles was confirmed at 50 nm, while the 250 nm
particles appeared to be smaller, namely 200 nm by
tracking analysis versus 210 nm by TEM.
The gold particles of 50 nm appeared to be monocrys-
talline; the diffraction maxima and the lattice images
pointed to pure Au (data not shown). Some gold parti-
cles of 250 nm consisted of two or three smaller not
intimately connected particles. An example is shown in
figure 2A. These composite 250 nm particles do not
exhibit a monocrystalline diffraction pattern and a sphe-
rical or facetted shape as the 50 nm particles (data not
shown). figure 2B represents three gold particles of
about 250 nm. The secondary electron image demon-
strated the individual particles to be well facetted, while
other gold particles were fractured and had thus no
symmetrical shape (figure 2C). The high-angle annular
dark field (HAADF) images of both the 50 and the
250 nm particles showed the presence of areas contain-
ing carbon and oxygen on which some silicon contain-
ing areas were present, most likely in the form of SiO2
(data not shown). The carbon and oxygen may be due
to the presence of citrates.
Biological response
Three and 24 hours after instillation, several parameters
were determined in the BALF. Single 250 nm particles
induced a significant increase in the percentage of neu-
trophils after 24 hours (table 2). The percentage differ-
ential cell counts 24 hours after instillation showed that
t h e r ei sas h i f tt o w a r d san e u t r o p h i li n f l u xa tt h e
expense of the percentage of macrophages compared to
Table 1 Particle size distribution and zetapotential
highest peak size ± sd mean size ± sd zetapotential (mV) ± sd
50 nm gold single 54 ± 3 61 ± 3 -56 ± 0,42
50 nm gold agg 114 ± 73 199 ± 88 -54 ± 1,01
250 nm gold single 197.5 ± 7 197 ± 12 -53 ± 0,53
250 nm gold agg 762 ± 762 768 ± 766 -61 ± 0,98
Highest peak size and mean particle size in this distribution is determined by tracking analysis of Brownian motion. Zetapotential is determined by using the
Zetasizer instrument.
Figure 1 TEM of single 50 and 250 nm particles. A) Primary
particle size of 50 nm gold particles was confirmed. B) The average
primary particle size 250 nm gold particle was assessed at 210 nm.
Bars represent 100 nm.
Figure 2 TEM of 250 nm particles. A) Some 250 nm gold particles
consisted of multiple smaller units of about 50 nm. B) Secondary
electron image of well faceted and grouped 250 nm particles. C)
Example of a fractured 250 nm gold particle, secondary electron
image. Bars represent 100 nm.
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agglomerates where the percentage in differential cell
count did not change, albeit a trend towards an increase
in total number of cells and absolute number of macro-
phages has been observed (table 2). This neutrophil
influx was minor after gold particle treatment and much
larger after quartz that is used as a reference material
for inflammation (table 2 and figure 3). After quartz
instillation, there was a significant increase in total cell
numbers as well as macrophages after 3 hours and
neutrophils after 24 hours. In addition, an increase in
MIP-2 (figure 4A) and a tendency to an increase in
MCP-1 levels (data not shown) was found, as expected
[27]. TNF-a and IL-6 levels were around the detection
limit. After instillation of 250 nm single gold particles, a
trend towards an increase was found for IL-6 (figure 4B)
and TNF-a levels (figure 4C). Agglomerated 50 nm par-
ticles resulted in increased levels of TNF-a after 3
hours, albeit not significant (figure 4C).
Analysis of damage markers total protein and albumin
revealed no significant differences in the BALF after
gold instillation (data not shown). The agglomerated 50
nm particles induced an increase in ALP (alkaline phos-
phatase) activity after 3 hours (figure 5A). Increased
ALP activity in BALF has been associated with type II
epithelial cell damage [28]. Quartz at 1.6 mg/kg bw
resulted in cellular damage as can be seen by an
increase in ALP (figure 5A) and lactate dehydrogenase
(LDH) (figure 5B) after 24 hours.
Light microscopic analysis revealed dark coloured
material inside macrophages of animals that were dosed
with 50 nm and 250 nm particles, either agglomerated
or as single particles. In control animals that did not
receive any particles, no material was seen (Additional
file 1, Figure S1). For both sizes of particles, 60-80 out
of 100 macrophages contained this material. Transmis-
sion electron microscopy images showed that 50 nm
and 250 nm particles were taken up by alveolar macro-
phages when the particles were administered either as
single particles (figure 6A, 6B, 6C, 6D), as 50 nm
agglomerated particles (figure 6F and 6G) or as 250 nm
particles (figure 6H and 6I). Analysis of elements in
HAADF mode confirmed that it were indeed gold parti-
cles (figure 6E).
No significant differences in vWF and IL-6 levels
in citrate plasma were found (data not shown). Single
250 nm and agglomerated 50 nm gold particles
increased fibrinogen levels after 24 hours (figure 7A).
After gold and quartz instillations CRP levels were ele-
vated compared to the negative control after 3 hours
(figure 7B). Upregulation of these acute phase proteins
indicate a general response to tissue injury.
Discussion
Size differences as well as the agglomeration state of
citrate stabilized gold particles of 50 nm and 250 nm
have been determined and the impact on the biological
response in the lung has been established in this study.
Size is one of the important characteristics for the
deposition pattern and fate of particles in the body. Par-
ticle size affects the accessibility of target organs, the
mode of cellular uptake, endocytosis and efficiency of
particle processing in the endocytic pathway. Here, we
show that 50 nm gold particles that were administered
as a well dispersed single particle suspension or as an
agglomerated suspension are taken up by macrophages.
The particles end up in the cytoplasm inside vesicles
and not in other structures. This has also been observed
Table 2 Cell, macrophage and neutrophil concentration in BALF
Total cell (10E6/ml) Macrophage 10E6/ml) Neutrophil (10E5/ml)
Treatment 3 hrs 24 hrs 3 hrs 24 hrs 3hrs 24 hrs
- control 0.29 ± 0.05 0.72 ± 0.17 0.23 ± 0.06 0.61 ± 0.14 0.09 ± 0.02 0.57 ± 0.44
50 single 0.29 ± 0.04 0.71 ± 0.20 0.22 ± 0.04 0.55 ± 0.19 0.14 ± 0.07 0.99 ± 0.49
250 single 0.30 ± 0.11 0.74 ± 0.19 0.26 ± 0.11 0.49 ± 0.13 0.22 ± 0.16 1.5 ± 0.84*
50 agg 0.30 ± 0.10 0.54 ± 0.23 0.25 ± 0.10 0.39 ± 0.20 0.17 ± 0.13 1.0 ± 0.59
250 agg 0.36 ± 0.08 1.02 ± 0.45 0.30 ± 0.06 0.84 ± 0.42 0.19 ± 0.18 1.0 ± 0.76
quartz 0.54 ± 0.31* 2.16 ± 0.62* 0.47 ± 0.28* 0.32 ± 0.15 0.27 ± 0.14 17.2 ± 7.6*
Average concentration ± sd. Statistical significant differences P < 0.05 are indicated by *
0%
20%
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100%
- control
50 single
250 single
50 agg
250 agg
quartz
Basophils
Lymfocytes
Eosinoph. granuloc.
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Macrophages
Figure 3 Differential cell counts in BALF. The percentage
macrophages, neutrophils, eosinophilic granulocytes, lymphocytes
and basophils were given per treatment group 24 hours after
instillation (n = 6 for gold and n = 3 for quartz).
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gold particles [21]. In all cases, nanoparticles were sur-
rounded by a membrane (figure 6), indicating that the
uptake of the nanoparticles occurred by endo- or phago-
cytosis. Certain vesicular structures contain a single NP
of 50 nm, whereas others contain more than just one.
There is evidence for macrophage phagocytic function
to be size dependent [5]. Alveolar macrophages phago-
cytise spherical particles of 1-2 μmm o s te f f e c t i v e l ya n d
uptake has been seen up to 5 μm [29]. In vitro, particles
of 300 nm are less well phagocytised compared to 5 μm
[30]. Particle uptake in macrophages for nano-sized
TiO2 has been estimated to be between 0.06 and 0.12%
within 24 hours compared to micron sized particles. For
the latter, 10% uptake is seen within the first hour [31]
and more than 80% within 24 hours [15]. The set-up of
this study did not allow quantification of the uptake.
Although under the light microscope, the number of
macrophages that were filled with material seemed com-
parable, it was more difficult to visualize macrophages
containing 250 nm particles after 24 hours than 50 nm
particles in TEM evaluation. This has also been seen
before in our unpublished pilot study where we could
visualize 250 nm particles in only a few macrophages.
The overall findings on biological parameters after
gold instillation based on the pulmonary and blood mar-
kers are summarized in table 3. MIP-2 and MCP-1 were
only affected by quartz and are therefore not mentioned
in the table. TNF-a and IL-6 levels after quartz instilla-
tion were around detection levels as determined in two
independent experiments using ELISA kits from differ-
ent manufacturers. In literature, controversial results
have been described with respect to increased TNF-a
and IL-6 levels after quartz exposure. While some in
vivo studies do show a significant increase [32], other
studies only show an increase in vitro and not in vivo
Figure 4 Cytokine profile in BALF 3 and 24 hours after instillation. A) MIP-2 levels are significantly increased after quartz instillation. * P <
0.05 (n = 6 for gold and n = 3 for quartz) B) No significant differences were found in IL-6 levels. A trend towards an increase is seen after
instillation of 250 nm single gold particles. C) A trend towards an increase in TNF-a levels was found for 250 nm single gold particles and
agglomerated 50 nm particles.
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quartz that is partly TNF-a independent has been pos-
tulated [34].
When comparing 50 nm single versus 50 nm agglom-
erated particles, most changes on biological variables
were found after instillation of agglomerated nanoparti-
cles: a significant increase in ALP, fibrinogen and CRP
is accompanied by a trend towards a neutrophil influx
and an increase in TNF-a levels. Single 50 nm particles
induced an increase in CRP levels and there was a trend
towards an increase in neutrophils. Single 250 nm parti-
cles increased the number of neutrophils and the levels
of fibrinogen and CRP. The response was accompanied
by a trend towards an increase in TNF-a and IL-6.
Agglomerated 250 nm particles only induced a signifi-
cant increase in CRP. Moreover a (statistically not sig-
nificant) increase in total cell number and the number
of macrophages was noted. TNF-a is mainly produced
by macrophages and stimulates phagocytosis. It also acts
together with IL-6 (trend towards increase) by promot-
ing inflammation by attracting neutrophils [35]. After
increases in circulating TNF-a, the liver is stimulated to
produce acute phase proteins like C-reactive protein
(CRP) and fibrinogen. Most effects were found for single
250 nm particles, since all these parameters were
affected. The 250 nm agglomerates, 50 nm agglomerates
(that are the same mean size as the primary 250 nm
particles) or 50 nm single particles did not affect these
parameters to the same extent (table 1).
The hypothesis that single nanoparticles could be
more toxic than larger counterparts either formed by
agglomeration or larger primary size particles does not
apply to the gold particles that were administered here
in a single dose of 1.6 mg/kg bw to the lung. The least
effects in this study were seen after administration of
single 50 nm particles. At least two reasons have been
hypothesized to explain why NPs could be more toxic:
1. there are more reactive atoms on the surface and
more surface per unit mass. 2. nanoparticles that are
small enough could exert quantum effects due to con-
straint chemical bonds that are more likely to be dis-
rupted [36]. A recent systematic literature overview by
Auffan et al. suggested that inorganic metal and metal
oxide nanoparticles with a primary particle size below
20-30 nm are likely to show different chemical proper-
ties not seen in bulk material [37]. In the case of gold,
catalytic activity has been observed for particles of smal-
ler than 10 nm [38,39]. The nanoparticles of 50 nm
used in this study are not likely to induce increased bio-
logical responses due to enhanced chemical reactivity
compared to the submicron sized gold particles.
When suspended in PBS instead of ultrapure water,
our study showed a 2-4 times increase in overall particle
size. Particle agglomerate and aggregate formation in
physiological media such as PBS has been observed for
a number of different types of particles smaller than 100
nm resulting in entities that were 3-6 times larger [11].
These effects are influenced by pH, ionic strength, and
different types of ions in aqueous suspensions [40].
Agglomerates are held together by weak forces such as
van der Waals forces, electrostatic interactions or sur-
face tension. After 5 minutes, 50 nm particles assembled
to form large precipitates that could not be brought
back into suspension using e.g. sonication. The gold
Figure 5 Cell damage markers in BALF 3 and 24 hours after instillation. A) Alkaline phosphatase (ALP) levels are significantly increased 3
hours after 50 nm gold agglomerates and 24 hours after quartz instillation. * P < 0.05 compared to negative control, ** P < 0.05 compared to
50 nm single gold particles. B) LDH levels are significantly increased 24 hours after quartz instillation (n = 6 for gold and n = 3 for quartz).
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Page 6 of 11Figure 6 TEM of macrophages in BALF 24 hours after instillation. Uptake of 50 nm gold particles. Panels A-E concern instillation of gold
particles in ultrapure water, panels F and G concern gold particles in PBS. A) Alveolar macrophage with multiple organelles containing 50 nm
gold particles that were instilled as a well dispersed suspension containing single particles. B) Enlargement of the square in A, shows the
presence of cellular structures containing one or more nanoparticles. C) Accumulation of agglomerates of nano-particles within organelles
(arrows); the insert represents the vesicular structure containing over 25 nanoparticles in the black square. D) Same macrophage as shown in
C now in HAADF mode. E) An EDX HAADF analysis has been performed on the nanoparticle indicated with an * in the insert and the presence
of gold (Au) is confirmed. F) Agglomerated 50 nm gold particles were observed in the macrophages, although heterogeneity in cellular uptake
is observed. G) Enlargement of the square in F. H) 250 nm gold particles were also found in the macrophages with an enlargement of the
square in I). The bars represent: A, C, D: 2 μm, B: 500 nm, inserts C/D: 100 nm, F and H: 5 μm, G and I: 1 μm.
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of the weakly bound citrate coating [41]. Gold colloids
are vulnerable to agglomeration due to the compensa-
tion of the electrostatic repulsive force by the high ionic
strength of phosphate buffered saline (PBS) [42]. In the
present study we have carefully avoided this phenom-
enon by applying the suspensions to the animals and
using the suspensions for chemical analyses immediately
after preparation.
Extensive characterization of the particles revealed
that the size of the 50 nm particles corresponds to the
manufacturer’s description. The 250 nm particles turn
out to be significantly smaller and some are build-up
from several nano-sized particles, whereas the 50 nm
particles were monocrystalline. It turns out to be diffi-
cult to obtain gold particles with exactly the same char-
acteristics with only the primary size as a variable. Due
to differences in the production process, the 250 nm
particles may have a different appearance and build-up
compared to 50 nm particles as was shown by electron
microscopy techniques.
Conclusions
Both single and agglomerated 50 nm and 250 nm parti-
cles generate a mild inflammatory reaction after intra-
tracheal instillation as indicated by small increases in
inflammatory cells, pro-inflammatory cytokine produc-
tion or acute phase protein expression. The effects are
the least for single 50 nm gold particles. Both agglomer-
ated as well as single nanoparticles were taken up by
macrophages.
Extensive particle characterization reveals that primary
particle size, concentration of the gold suspension and
particle purity are important features to check, since
these characteristics may deviate from the manufac-
turer’s description. The hypothesis was that the lung
might deal differently with agglomerated and single
citrate stabilized gold nanoparticles of different sizes
Figure 7 Acute phase protein in serum 3 and 24 hours after instillation. A) Fibrinogen levels are significantly increased after 250 nm single
and 50 nm agglomerated particles. B) CRP levels are significantly increased 3 hours after gold and quartz treatment. * P < 0.05 compared to
negative control (n = 6 for gold and n = 3 for quartz).
Table 3 Overview significant changes and trends after gold instillation
Local pulmonary effects Systemic effects
Inflammatory cells Cytokines Cell damage Acute phase proteins
Cells Macrophages Neutrophils IL-6 TNF-a ALP Fibrinogen CRP
50 nm single - - ↑ -- - - ↑*
250 nm single - - ↑* ↑↑ - ↑* ↑*
50 nm agg - - ↑ - ↑↑ * ↑* ↑*
250 nm agg ↑↑ -- - - - ↑*
quartz ↑↑*- ↑↑*- - ↑↑*- ↑*
* indicates a statistically significant effect (P < 0.05).
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m a j o rd i f f e r e n c e s .W ec o n c l u d et h a ts i n g l e5 0n mg o l d
particles do not pose a greater acute hazard than their
agglomerates or slightly larger gold particles when using
pulmonary inflammation as a marker for toxicity.
Methods
Animals
Male WU Wistar-derived rats of 8 weeks of age and
around 250 grams of body weight were obtained from
Harlan, The Netherlands. Animals were bred under SPF
conditions and kept barrier maintained during the
experiment. Conventional feed (Special Diets Services)
and tap water were provided ad libitum. Husbandry
conditions were maintained according to all applicable
provisions of the national law: Experiments on Animals
Act. The experiment was approved by an independent
ethical committee prior to the study.
Experimental set-up
As i n g l ed o s eo f1 . 6m g / k gb wi n0 . 5m lo f5 0n mo r
250 nm gold particles was delivered in the rat lung by
intratracheal instillation under isoflurane anaesthesia.
T h e5 0n ma n d2 5 0n mg o l ds u s p e n s i o n s( B B II n t e r n a -
tional, UK) were custom prepared at 2 mg/ml. Solutions
containing the same trace elements and reagents except
for 50 and 250 nm gold particles (BBI International,
UK) were used as a vehicle control (4.5 volumeparts
c o n t r o ls o l u t i o n5 0n ma n d4 . 5p a r t s2 5 0n mc o n t r o l
solution and 1 part ultrapure water). Suspensions con-
taining single 50 nm or 250 nm particles were prepared
by diluting 9 volumeparts of 50 or 250 nm particles
with 1 volumepart sterilized ultrapure water. Agglomer-
ated (agg) suspensions were prepared by diluting 9
volume parts of particles with 1 volumepart sterilized
10× PBS. A single dose of 1.6 mg/kg bw quartz (DQ12,
crystalline silica) in ultrapure water was used as a posi-
tive control. All solutions were sonicated for 30 seconds
in an ultrasonic water bath prior to administration to
the animals. Animals were sacrificed at 3 hours or
24 hours after administration of the particles, and
bronchoalveolar lavage fluid (BALF) and blood were col-
lected. Treatment groups for gold consisted of 6 animals
and for quartz of 3 animals.
Characterization of gold particles and quartz
Gold particles of 50 nm and 250 nm particles were pur-
chased in sterile bottles and contained besides colloidal
gold with a citrate shell, trace elements of substances
used during synthesis. Endotoxin levels of the gold solu-
tions of 50 and 250 nm were determined in a LAL assay
and there were no detectable levels. The pH of the 50
and 250 nm solutions and control solutions were mea-
sured using indicator strips in the range of pH 1-10 and
6.4-8.0 (Merck). The zetapotential (Zetasizer, Malvern
Instruments, UK) was determined in a triplicate mea-
surement of a 20 μg/ml sample as a 10% dilution with
ultrapure water or 10× PBS. The samples were first
diluted with either ultrapure water or 10× PBS and then
further diluted to the desired concentration using ultra-
pure water. Prior to preparing the quartz solutions,
DQ12 was baked at 220°C for 3 hrs to inactivate possi-
ble endotoxin on the particle surface.
The concentration of gold in the commercial available
solutions was determined by Inductively Coupled
Plasma-Mass Spectrometry (ICP-MS) by MiPlaza Mate-
rials Analysis, Philips, Eindhoven, the Netherlands.
Three independent samples were digested with aqua
regia in a heating block system. The size distribution of
the 50 nm and 250 nm gold particles directly after pre-
paring the suspensions for intratracheal instillation were
determined in 6 separate measurements using tracking
analysis of Brownian motion with a laser illuminated
microscopical technique (LM20, NanoSight Ltd, UK).
The size of the 250 nm agglomerates were in the maxi-
mal range of the measurement technique resulting in
three representative measurements.
Transmission electron microscopy (TEM) analysis
A Tecnai 20F electron microscope equipped with a field-
emission gun operated at 200 kV was employed to investi-
gate the structure and the chemical composition of the
gold particles with diameters of 50 and 250 nm. Samples
were prepared by putting a drop of the suspension of the
gold particles on a holey carbon film applied on a copper
grid placed on filter paper. The gold particles were present
well dispersed on the carbon film. Images were taken
using conventional transmission electron microscopy
(TEM) and scanning transmission electron microscopy
(STEM) with a high-angle annular dark-field (HAADF)
[43] and a secondary electron detector. STEM enabled us
to execute elemental analysis by energy-dispersive X-ray
(EDX) analysis at predefined spots. To assess the crystallo-
graphic structure of the gold particles, selected area elec-
tron diffraction and lattice imaging were performed.
TEM analysis of particles in lung cells in the BALF
was performed by pooling cells per exposure group and
by fixation in 2% glutaraldehyde in cacodylatebuffer (pH
7.2-7.2), supplemented with 0.025 mM CaCl2 and 0.05
mM MgCl2. The cells were embedded in gelatin, which
was allowed to solidify to obtain “cell-tissue-blocks”.
The blocks were fixed in 4% paraformaldehyde (PFA),
and postfixed with osmium tetroxide (OsO4) and potas-
sium ferrocyanide (KFeCN), dehydrated with the use of
ethanol and embedded in Epon. Ultrathin sections were
made, post stained with lead citrate and uranylacetate
and examined in a FEI Tecnai 12. Of the 24 hr groups
at least three sections out of 12 sections were analyzed.
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At 3 and 24 hours after intratracheal administration,
rats were anesthetized via i.p. injection with a mixture
of Ketamine/Rompun and sacrificed by exsanguination
via the abdominal aorta. The lungs were perfused with
saline to remove all the blood in the tissue. After liga-
tion of the left bronchus, the right lung was lavaged
(three in-and-out lavages with the same fluid) with a
volume of saline corresponding to 27 ml/kg of body
weight at 37° to obtain BALF.
BALF was analyzed for the following parameters: total
cell number (Coulter counter), differential cell count of
400 cells (cytospins), monocyte chemotactic protein -1
(MCP-1, Invitrogen), tumor necrosis factor a (TNF-a,
Arcus Biologicals and eBiosciences), interleukin-6 (IL-6,
Demeditec Diagnostics and eBiosciences) and macro-
phage inflammatory protein -2 (MIP-2, Arcus Biologi-
cals). LDH, ALP, albumin and total protein were
measured using an autoanalyser (LX20-Pro, Beckman-
Coulter, Woerden, the Netherlands) using kits from the
same manufacturer.
EDTA blood was used to determine the total number
of cells and differential cell count. In citrate plasma,
protein levels of van Willebrand factor (vWF, American
Diagnostica), fibrinogen (Genway) and C-reactive pro-
tein (CRP, Helica Biosystems) were determined.
Statistics
Data were analyzed by analysis of variance (ANOVA
single factor) and where appropriate by a Bonferroni
post-hoc analysis (Graphpad Prism). Differential cell
count data are not normally distributed; therefore, the
Kruskal-Wallis nonparametric test was used. Statistical
significance is indicated with a * (P value < 0.05). In all
graphs, error bars represent the standard deviation of
the mean.
Additional material
Additional file 1: Figure S1: Light microscopic images of particulate
material in macrophages. A) No particulate material is found inside
macrophages from BALF in animals receiving the vehicle control. B and
C) Animals received 50 nm gold particles. Black particulate material is
seen in the cytoplasm (blue) and not in the nucleus (purple) of
macrophages. D) Black particulate material is observed in macrophages
of animals that received 250 nm gold particles. Bars represent 12 μm.
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